| Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy S Delgado-Tirado, D Amarnani, G Zhao, EJ Rossin, D Eliott, JB Miller, ... Scientific reports 10 (1), 20554, 2020 | 23 | 2020 |
| Targeting runt-related transcription factor 1 prevents pulmonary fibrosis and reduces expression of severe acute respiratory syndrome coronavirus 2 host mediators M O'Hare, D Amarnani, HAB Whitmore, M An, C Marino, L Ramos, ... The American Journal of Pathology 191 (7), 1193-1208, 2021 | 17 | 2021 |
| Characterization of a murine model of oxazolone-induced orbital inflammation D Amarnani, AV Sanchez, LL Wong, BV Duffy, L Ramos, SK Freitag, ... Translational Vision Science & Technology 9 (8), 26-26, 2020 | 4 | 2020 |
| Effect of rho-kinase inhibition on a patient-derived model of proliferative vitreoretinopathy L Ramos, D Amarnani, N Singh, LA Kim Investigative Ophthalmology & Visual Science 62 (8), 3641-3641, 2021 | 1 | 2021 |
| An Explant Model of Human Proliferative Vitreoretinopathy Uncovers Synergistic Effects of Methotrexate and RUNX1 inhibition J Arboleda-Velasquez, D Amarnani, L Ramos, S Delgado-Tirado, LA Kim Investigative Ophthalmology & Visual Science 60 (9), 6419-6419, 2019 | | 2019 |
| RUNX1 Regulation of Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy D Amarnani, L Ramos, S Delgado-Tirado, W Greene, HCH Wang, LA Kim, ... Investigative Ophthalmology & Visual Science 60 (9), 5811-5811, 2019 | | 2019 |
